Cognex (CGNX)

Technology · Scientific & Technical Instruments
$60.39 -8.98% on the day Market cap $10.1B 52-week range $34.60 to $72.88 Prices as of Oct 7, 2026

What the price implies

A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.

Free cash flow growth the price needs
15% a year for 10 years

At a market value of $10.1B, Cognex's free cash flow of $237M (fiscal 2025) would need to grow about 15% a year for the stock to be worth today's price. That is faster than the company has grown its free cash flow over the last 9 years.

Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from Cognex's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.

Implied by the price15.0% a year
Free cash flow, last 9 years3.8% a year
Revenue, same period7.3% a year
Price to free cash flow42.9x

Fundamental grade

B

Five factors scored 1 to 9 from CGNX's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.

Valuation2
Profitability7
Growth8
Financial health8
Cash efficiency9

Key numbers

P/E (trailing)71.7x
P/E (forward)32.2x
Price / free cash flow42.9x
EV / EBITDA35.4x
Price / sales9.32x
Price / book7.01x
Revenue growth+16.9%
Operating margin21.9%
Net margin16.1%
Return on equity10.7%
Dividend yield0.53%
Debt / equity0.34x

Results from SEC filings

Fiscal years, from Cognex's 10-K filings. The deep dive has 15+ years, quarters and every line.

Fiscal year20212022202320242025
Revenue$1.0B$1.0B$838M$915M$994M
Net income$280M$216M$113M$106M$114M
Free cash flow$299M$224M$90M$134M$237M
EPS (diluted)$1.56$1.23$0.65$0.62$0.68
Operating margin30.4%24.5%15.6%12.6%16.3%

Where the revenue comes from

Revenue by products, fiscal 2025.

Standard products and services (1)$880M89%
Application-specific customer solutions$114M11%

Superinvestors who own CGNX

From each investor's latest 13F filing (what a 13F shows). 4 of the investors we track hold it.

InvestorLast quarterValue% of portfolioQuarter
Cliff Asness
AQR Capital Management
Trimmed $102M0.04%Q2 2026
Ron Baron
Baron Capital (BAMCO)
Trimmed $91M0.14%Q2 2026
Joel Greenblatt
Gotham Asset Management
Trimmed $37M0.09%Q2 2026
Glenn Welling
Engaged Capital LLC
Trimmed $25M7.6%Q2 2026

Insider buying

Open-market purchases by Cognex's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.

No open-market insider purchases of CGNX in the last 12 months. Most insider activity is selling and option exercises, which aren't shown here.

Get an alert at your buy price

Pick the price you'd be interested at. We'll email you when CGNX trades at or below it.

$

Free accounts get 3 price alerts. No card needed.

In the full deep dive

DCF fair value per share
Yearly return (IRR) at today's price
Growth implied by revenue and margins
15+ years of statements and quarters

Questions

What growth does Cognex's stock price imply?

At a market value of $10.1B, Cognex would need its free cash flow to grow about 15% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 4% a year.

Are Cognex insiders buying the stock?

No open-market insider purchases of CGNX in the last 12 months, according to SEC Form 4 filings.

Which superinvestors own Cognex?

4 of the superinvestors Investingly tracks hold CGNX in their latest 13F, including Cliff Asness, Ron Baron, Joel Greenblatt.

Prices and ratios as of Oct 7, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.